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Abstract 
Proteins, the workhorses of the cell, are immensely important to biological 
processes in all forms of life. Cellular signaling is a vital component of cellular 
function in which proteins play a major role. This thesis research focuses on 
two distinct proteins, an oncoprotein (v-ErbA) and a pseudophosphatase (MK-
STYX), and their role in responses to extracellular signals. The retroviral 
oncoprotein v-ErbA (p75gag-v-ErbA) is a highly mutated variant of the thyroid 
hormone receptor α1 (TRα1) that interferes with cellular response to thyroid 
hormone. v-ErbA has been observed to form punctate cytoplasmic foci 
reminiscent of aggresomes, perinuclear accumulations of misfolded proteins. 
Aggresomes have several key features; specifically, this research provides 
evidence that v-ErbA foci, like aggresomes, colocalize with proteasomes and 
mitochondria. Additionally, v-ErbA aggresome formation is dependent upon 
the viral Gag sequence. These studies provide evidence that v-ErbA is 
recruited to aggresomes, highlighting a complex mode of oncogenesis across 
several cellular compartments. The second protein, MK-STYX [MAPK 
(mitogen-activated protein kinase) phospho-serine/threonine/tyrosine-binding 
protein] is a pseudophosphatase member of the dual-specificity phosphatase 
subfamily of the PTPs (protein tyrosine phosphatases). MK-STYX lacks 
catalytic activity due to the absence of two key amino acids from the signature 
motif that are essential for phosphatase activity. MK-STYX is known to bind 
G3BP, an RNA-binding protein that is involved in stress granule assembly, 
and decreases stress granule formation. This thesis research provides 
evidence that MK-STYX inhibition of G3BP-induced stress granule formation 
is not phosphorylation-dependent; MK-STYX still decreased stress granule 
assembly in cells expressing a non-phosphorylatable G3BP mutant. 
Additionally, an active mutant of MK-STYX was able to induce stress granule 
assembly in cells expressing the phosphomimetic G3BP-S149E. Finally, MK-
STYX is homologous to a class of phosphatases responsible for regulating 
MAP kinase pathways, which are involved in diverse processes of cellular 
growth and differentiation. In PC12 cells, a model of neuronal differentiation, 
MK-STYX appears to induce the formation of multiple small outgrowths in 
untreated cells and enhances the length of outgrowths in cells treated with 
NGF. This data indicates a potential role in regulation of cellular response to 
extracellular signals. In summary, this project elucidates the recruitment of v-
ErbA to aggresomes, and the pseudophosphatase MK-STYX as a regulator of 
the cellular stress response and neuronal differentiation. 
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General Introduction 
Cellular signaling and communication 
Cell signaling is a complex system of communication responsible for 
governing basic cellular activities and physiological functions. Critical to these 
processes is the ability of cells to perceive and respond to their environment. 
These communication systems depend heavily on extracellular signaling 
molecules, which are produced by cells to signal to their neighbors or other 
cells further away. These signal molecules interact with receptor proteins that 
transmit the signal to the necessary parts of the cell, initiating shifts in DNA 
expression, protein function, and progression in the cell cycle. Response to 
extracellular signals governs such diverse processes as growth and 
development, immunity, apoptosis, and homeostasis; misregulation of this 
cellular response can result in cancer, diabetes, and inflammation, among 
other diseases.  
 
This thesis research encompasses two projects. The first portion of this 
research involved the characterization of a highly mutated variant of the 
thyroid hormone receptor, v-ErbA. This oncogenic variant, which is carried by 
the avian erythroblastosis virus, interferes with normal cellular response to the 
thyroid hormone. Notably, prior research has indicated that it has altered 
subcellular distribution with respect to the thyroid hormone receptor and forms 
large, perinuclear aggregates (Bonamy et al., 2005; DeLong et al., 2004). 
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These aggregates resemble aggresomes, sites of misfolded proteins that 
accumulate at the microtubule organizing center. This research aimed to 
determine whether v-ErbA foci are aggresomal in nature. Additionally, 
investigation of the AEV Gag sequence provides a potential rationale for the 
recruitment of v-ErbA to these foci.  
 
The second component of this work was the characterization of a novel 
protein, the pseudophosphatase MK-STYX. MK-STYX, though it is 
catalytically inactive, has sequence homology to the MAP kinase 
phosphatases (MKPs), a class of proteins that is responsible for modulating 
the duration of MAPK signaling. MK-STYX has been shown to affect 
endogenous and stress granule assembly induced by G3BP (Hinton et al., 
2010). This thesis research determined whether MK-STYX inhibition of stress 
granule formation is phosphorylation-dependent. MK-STYX is homologous to 
a class of proteins called MKPs, which are expressed in PC12 rat 
pheochromocytoma cells.. Thus, we investigated the effect of MK-STYX on 
MAPK signaling in these cell lines.  
 
Part 1: The targeting of v-ErbA to aggresomes  
The thyroid hormone receptor 
The thyroid hormone receptor (TR) is a nuclear hormone receptor that alters 
transcription of genes involved in homeostasis, development, and metabolism 
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in response to thyroid hormone (T3).  There are two major forms of thyroid 
hormone receptor, TRα1 and TRβ1; the focus of this thesis research will be 
TRα1 and its variants. TRα1 (hereafter referred to as TRα) binds to target 
genes both in the presence and absence of its ligand. When bound to T3, 
depending on the response element to which TRα is bound, it can activate 
transcription of genes.  When T3 is absent, TRα represses these genes.  
Proper localization of the thyroid hormone receptor is integral in proper 
cellular response to thyroid hormone, particularly shuttling of the receptor 
between the cytoplasm and nucleus. Mutations in the nuclear localization 
sequence(s) of thyroid hormone receptor disrupt its transport into the nucleus, 
preventing it from interacting with thyroid hormone response elements and 
altering gene transcription. Evidence indicates that mislocalization of the 
receptor caused by mutations can lead to a variety of diseases, including 
cancer.   
 
v-ErbA 
The retroviral gag-v-ErbA oncoprotein (p75gag-v-ErbA) is a mutated derivative of 
TRα that is unable to bind thyroid hormone. v-ErbA was first isolated as one 
of two oncogenes carried by the avian erythroblastosis virus (AEV); the other 
oncoprotein, v-ErbB, is a highly mutated form of the epidermal growth factor. 
AEV causes erythroleukemia and sarcomas in chickens (Braliou et al., 2001). 
Mutations in its amino acid sequence, including the fusion of AEV Gag to its 
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N-terminus, N- and C-terminal deletions, and 13 amino acid substitutions 
throughout the protein, lead to detrimental effects in infected cells (DeLong et 
al., 2004) (Figure 1).   
 
v-ErbA has a dominant negative effect on TRα that was originally attributed to 
competition with TRα for T3-responsive elements or other aspects of gene 
regulation.  However, recent evidence has altered that understanding. It is 
now thought that oncogenic conversion of v-ErbA is linked to changes in DNA 
binding specificity and ligand binding properties, as well as altered nuclear 
export capabilities that result in a change in subcellular localization (Bonamy 
and Allison, 2006).   
 
Nuclear export of v-ErbA occurs through a CRM1-mediated pathway, in direct 
contrast to the partially CRM1-independent transport of TRα (DeLong et al., 
2004; Grespin et al., 2008). Prior studies have indicated that a nuclear export 
sequence resides within a 70-amino acid sequence in the C-terminal portion 
of the p10 region of the Gag sequence, which interacts directly with CRM1. 
Additional evidence suggests that, throughout its evolution, v-ErbA has lost 
the ability to follow the export pathway used by TRα (DeLong et al., 2004).  
 
As opposed to the primarily nuclear localization of TRα, v-ErbA localizes 
primarily to the cytoplasm with punctate distribution in cytoplasmic and  
 11 
  
 
 
Figure 1: Schematic Comparison of v-ErbA and TRα.  
This figure illustrates v-ErbA homology with TRα. v-ErbA differs from TRα by 
fusion with a retroviral Gag sequence and by several amino acid substitutions 
along with deletions at both ends. 
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nuclear foci (Bonamy et al., 2005; DeLong et al., 2004). Evidence suggests 
that v-ErbA dimerizes with TRα and the retinoid X receptor, sequestering a 
significant fraction of these receptors in the cytoplasm, where they cannot 
affect gene expression (Bonamy et al., 2005). Preliminary evidence 
suggested that these v-ErbA foci were linked to aggresomes, a cellular 
response to accumulations of misfolded protein.  
 
Protein folding and misfolding: an introduction to the aggresome 
Correct folding and maintenance of a newly synthesized amino acid chain into 
its three-dimensional conformation is required for proper protein function.  
This does not always occur; however, misfolding of proteins can be caused by 
mutations in the amino acid sequence, errors in translation, or environmental 
stresses.  Correctly folded proteins have their hydrophobic side chains 
embedded within the interior of the folded protein.  Misfolded proteins often 
expose hydrophobic domains, accumulate in the cytoplasm, and associate 
with other misfolded proteins, resulting in aggregation (Garcia-Mata et al., 
1999).  Protein aggregation is linked to many diseases, including Alzheimerʼs, 
Huntingtonʼs, and Parkinsonʼs disease (Boeddrich et al., 2003; Tanaka et al., 
2004; Waelter et al., 2001). Generally, misfolded and aggregated proteins are 
refolded with the aid of chaperones or degraded by proteasomes or the 
autophagic process. However, a third possibility exists—the formation of 
aggresomes (Garcia-Mata et al., 2002).  
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Mechanism of aggresome formation  
Aggresomes are conglomerations of misfolded proteins that coalesce at the 
microtubule organizing center (MTOC) and are believed to be a mechanism 
for dealing with misfolded proteins in the cytoplasm.  Large, mature 
aggresomes form when smaller aggregates are carried along the microtubule 
tracks by the dynein/dynactin motor complex towards the nucleus (Garcia-
Mata et al., 2002). 
 
Once the smaller aggregates reach the nucleus, they form a large aggregate 
of loosely associated particles surrounding the MTOC.  This causes a 
disruption of the vimentin intermediate filament network, which collapses 
around the aggregated protein (Garcia-Mata et al., 1999).  Mature 
aggresomes have been shown to recruit chaperones, proteasomes, ubiquitin, 
and mitochondria.  Despite this recruitment, aggregates are only partially 
degraded (Garcia-Mata et al., 2002).  However, the aggresome also induces 
autophagy, directing them to the lysosome for degradation (Fortun et al., 
2003).  Thus, the aggresomal pathway may act as a way to transport 
aggregated proteins from the cytoplasm into lysosomes.   
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Degradation and clearance mechanisms induced by the aggresome 
The ubiquitin-proteasome system is a mechanism of protein turnover in which 
the protein of interest is linked to ubiquitin molecules that target the protein to 
the proteasome. The most common eukaryotic proteasome complex, the 26S  
proteasome, consists of a 20S core and two 19S regulatory caps. The 19S 
caps bind ubiquitinated proteins, remove ubiquitin, and unfold the substrate. 
At the 20S core, proteins are cleaved at peptide bonds to create short peptide 
fragments. It is reported that proteasomes are recruited to the aggresome, 
possibly to aid in degradation of accumulated misfolded protein (Garcia-Mata 
et al., 1999; Lee and Lee, 2002). 
 
Rearrangement of cell components in response to the aggresome 
The aggresome triggers disruption of intermediate filaments such as vimentin 
(Garcia-Mata et al., 1999; Johnston et al., 1998). However, it does not disrupt 
other components of the cytoskeleton, such as the microfilaments and 
microtubules (Garcia-Mata et al., 1999). The structure and function of the 
endoplasmic reticulum, Golgi, and lysosomes do not appear to be altered. 
While the mitochondria remain functional, they are reported to migrate to the 
aggresome and to similar sites of viral assembly (Bauer and Richter-
Landsberg, 2006; Heath et al., 2001; Mittal et al., 2007; Nozawa et al., 2004; 
Wileman, 2007). This migration might be a mechanism to provide ATP to 
chaperones and proteasomes.  
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Naturally occurring aggresomes 
Aggresomes were first identified in connection with a mutant protein 
characteristic of cystic fibrosis (Johnston et al., 1998). This protein, the cystic 
fibrosis transmembrane regulator (CFTR), functions as a chloride channel 
when properly folded; when misfolded, it cannot be transported to the cell 
membrane and is unable to carry out normal functions. This malfunction is 
associated with cystic fibrosis. Aggresomes are associated with a variety of 
other disorders, particularly neurodegenerative diseases, including 
Huntingtonʼs disease, Parkinsonʼs disease, and Retinitis pigmentosa (Saliba 
et al., 2002; Waelter et al., 2001).  
 
Aggresome markers 
Aggresomes can be studied not only through naturally occurring proteins but 
also through synthetic protein constructs that mimic aggresome formation. 
These act as a model system to characterize aggresome composition, 
formation, and resulting cellular response. Additionally, these proteins are 
markers that act as reference points. The primary aggresome marker used in 
this thesis research is GFP-250, which is composed of green fluorescent 
protein (GFP) fused at its C-terminus to the first 250 amino acids of the 
protein p115 (Garcia-Mata et al., 1999). p115 is a 959 amino acid protein 
involved in the transport of cargo from the ER to the Golgi (Nelson et al., 
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1998). This truncated GFP-250 protein coalesces into a single structure at the 
MTOC that displays aggresomal characteristics. GFP-250 aggresomes 
require microtubules for their formation, reorganize vimentin, and recruit 
chaperones and proteasomes (Garcia-Mata et al., 1999) 
 
Part 2: The involvement of MK-STYX in the stress response and 
neuronal differentiation 
Protein phosphorylation and cellular communication 
Reversible protein phosphorylation is an important post-translational 
modification that has been shown to play a role in almost every cellular 
process. Phosphorylation states are controlled by kinases, which are 
responsible for adding phosphate groups to target proteins, and 
phosphatases, which cleave these groups from the protein residues. Because 
the first phosphatase was discovered a decade after the first kinase, research 
on phosphatases is less complete. However, it is now becoming clear that 
while kinases are responsible for setting the amplitude of a signal, 
phosphatases are key in determining the duration and rate of these cellular 
signals (Heinrich et al., 2002; Hornberg et al., 2005).  Understanding the 
regulation of dephosphorylation is an integral part of elucidating cellular 
signaling and biological processes, especially given growing evidence that 
phosphatases are involved in a wide variety of pathologies, including cancer, 
neurodegeneration, diabetes, and inflammation (Tonks, 2006).   
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Figure 2: Classification of Protein Tyrosine Phosphatases.  
PTPs can be classified into these subgroups based on sequence homology 
and presence of conserved functional or binding domains. Of note in this work 
are the MKPS, the active homologs of  MK-STYX.  
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Protein tyrosine phosphatases 
Unlike kinases, which are derived from a common ancestor, the 
phosphatases evolved in structurally and catalytically distinct families. The 
protein tyrosine phosphatases (PTPs) are a large, heterogeneous group of 
protein phosphatases (Neel and Tonks, 1997; Patterson et al., 2009; Tonks, 
2006). Protein tyrosine phosphatases are defined by their ability to 
dephosphorylate phosphotyrosine residues within a substrate. These proteins 
can be divided into four basic subgroups (Figure 3). The first, the “type I 
cysteine based PTPs”, encompass both the classical, tyrosine-specific “PTPs” 
and the “DUSPs”, or dual specificity phosphatases. The second group 
contains just one PTP, “the low-molecular mass PTP (LMWPTP)”, a type II 
cysteine-based and tyrosine-specific phosphatase. The third group is the 
“type III cysteine-based, tyrosine- and threonine-specific phosphatases”; this 
class includes three cell cycle regulators, Cdc25A, Cdc25B, and 
Cdc25C,which dephosphorylate cyclin-dependent kinases, thus regulating the 
cell cycle. Finally, the fourth class is the “aspartic acid based PTPs”, which 
include the EyA and HAD phosphatases (Patterson et al., 2009).  
 
 PTP signature motif and catalytic mechanism 
A hallmark of the protein tyrosine phosphatases is the signature motif, 
HCX5R, in which the cysteine and arginine residues are essential for 
catalysis. The catalytic mechanism shared by the PTPs is also characteristic 
 19 
of several other structurally diverse phosphatases. Dephosphorylation 
requires two steps mediated both by active site residues and nearby residues 
that stabilize the intermediates. In the first step, the phosphate group on the 
substrate is transferred to the catalytic cysteine in the signature motif in an 
SN2 nucleophilic attack; this is made possible by the neighboring histidine and 
arginine, which serve to lower the pKa of the cysteine and enhance its 
nucleophilic abilities at physiological pH. Additionally, the neighboring arginine 
is essential in stabilizing the transition state, resulting in a phosphocysteine 
intermediate. Surrounding residues stabilize the negative charge in the 
region, allowing a water molecule to position for nucleophilic attack on the 
phosphocysteine intermediate (Zhang, 1998; Zhang and Dixon, 1994).  
 
Dual specificity phosphatases 
As members of the PTP superfamily, a unique feature of dual specificity 
phosphatases is their ability to dephosphorylate both phosphotyrosine and 
phosphoserine/threonine residues within one substrate (Patterson et al., 
2009; Tonks, 2006). This is made possible by a shallower active site cleft that 
allows both tyrosine and serine/threonine to fit into the groove (Hinton et al., 
2010). DUSPs possess both the HCX5R consensus sequence and an aspartic 
acid upstream of this sequence that acts as a general acid/base catalyst and 
helps to stabilize the phosphoryl-intermediate (Patterson et al., 2009). DUSPs 
are classified into multiple subgroups that highlight their heterogeneous 
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nature (Figure 2). Of particular note are the MKPs (mitogen-activated protein 
kinase phosphatases), which are one of the best-characterized DUSP 
subgroups and the primary subject of this study. The MKPs include ten 
proteins that dephosphorylate MAP kinases (mitogen-activated protein 
kinases) at both phosphoserine/threonine and phosphotyrosine residues 
(Patterson et al., 2009). Once thought to act merely as antagonists of MAP 
kinase signaling cascades, there is growing evidence that MKPs are critical 
regulators of signaling, capable of positively or negatively impacting signal 
transduction.  
 
Receptor tyrosine kinases  
Receptor tyrosine kinases (RTKs) are a subclass of enzyme-linked receptors 
that phosphorylate specific tyrosine residues on intracellular signaling 
proteins. Of the 90 tyrosine kinases in the human genome, 58 are receptor 
tyrosine kinases (Robinson et al., 2000). They can be divided into 16 
structural subfamilies. In mammalian cells, these include the epidermal 
growth factor (EGF) receptors, the insulin/insulin-like growth factor receptors, 
the nerve growth factor (NGF) receptors, the platelet-derived growth factor 
receptors/macrophage colony-stimulating factor receptors, the fibroblast 
growth factor (FGF) receptors, the vascular endothelial growth factor (VEGF) 
receptors, and the ephrin (Eph) receptors.  
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Binding of a signal protein to the ligand-binding domain on the exterior of the 
cell activates the intracellular tyrosine kinase domain. Rearrangement of the 
cytosolic domains enables autophosphorylation, in which the kinase domains 
of the receptors can cross-phosphorylate each other on multiple tyrosines. 
This process contributes to the activation of the molecule in two ways. The 
first is that phosphorylation of tyrosines within the kinase domain increases 
the kinase activity of the enzyme. Additionally, phosphorylation of tyrosines 
outside the kinase domain generates high affinity docking sites for the binding 
of intracellular signaling proteins in the cell, which triggers the formation of a 
large intracellular complex. The result of this process is that phosphate 
groups are added to selected tyrosine side chains on both the receptor 
protein itself and on intracellular signaling proteins that go on to engage in 
downstream signaling within the cell (Alberts, 2008; Robinson et al., 2000).   
 
Ras: a ubiquitous signaling protein 
The Ras proteins are a class of proteins that are part of the Ras superfamily 
of monomeric GTP binding proteins. GTPases are proteins that are able to 
bind and hydrolyze guanosine triphosphate (GTP). The Ras superfamily 
includes five subfamilies: Ras, Rho, Rab, Arf, and Ran (Colicelli, 2004; 
Wennerberg et al., 2005).  Ras proteins generally contain a covalently 
attached lipid groups that help anchor them to the cytoplasmic face of the 
plasma membrane. There, they interact with other signaling molecules to 
 22 
relay signals from the cell surface to other parts of the cell, aiding in 
processes such as growth and differentiation. 
 
Ras is activated and inactivated by guanine nucleotide exchange factors 
(GEFs) and GTP-ase activating proteins (GAPs). GEFs promote the 
exchange of GDP for GTP, thereby activating Ras, while GAPs increase the 
rate of hydrolysis of bound GTP, inactivating Ras. Thus, the coupling of a 
receptor tyrosine kinase to a GEF drives Ras into its active state. It has been 
indicated that RasGAP (a GAP specific to Ras) may have an integral role in 
the transducing of signals by Ras. The N-terminal domain of RasGAP has an 
SH3 (SRC Homology 3) domain flanked by two SH2 (Src Homology 2) 
domains responsible for phosphotyrosine binding. The SH3 domain in 
RasGAP, it appears, is essential for transducing signals downstream of Ras 
in a MAPK-independent manner and is also essential for transformation by 
oncogenic Ras (Irvine et al., 2004).  
 
Mitogen-activated protein kinases 
Ras can activate a serine/threonine phosphorylation cascade that is highly 
conserved in eukaryotic cells: the mitogen-activated protein kinase (MAPK) 
pathways (Figure 3). MAPKs are activated by dual phosphorylation on TXY 
motifs (Robinson and Cobb, 1997). The prototypical MAP kinase cascade 
comprises a three kinase module, including a MAP kinase (or ERK) a   
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Figure 3: MAPK and MK-STYX signaling cascades in neuronal cells.  
Growth factors such as neurotrophins (including NGF) induce RTKS to signal 
to ERK/MAPK via a signaling cascade that begins with the small G-protein 
Ras. The Ras-dependent pathway is ubiquitous in signaling processes of 
growth and development. MKPs deactivate MAPKs by dephosphorylating 
them.  We propose that MK-STYX either binds a MAPK or binds to the MKP.  
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MAPK/ERK kinase (MEK), and a MEK kinase (MEKK) (Robinson and Cobb, 
1997). In this cascade, a receptor tyrosine kinase or other enzyme-linked 
receptor would receive a signal from the exterior of the cell, generally in the 
form of a signaling molecule. Then, the RTK would activate Ras in the 
mechanism discussed above. From there, Ras activates a MEKK, Raf. Raf 
phosphorylates the MEK at two serines, thereby activating it (Alessi et al., 
1994). Finally, the MEK, or MAP kinase kinase, catalyzes phosphorylation of 
both a threonine and a tyrosine on a MAP kinase. This MAP kinase, now 
activated, can phosphorylate target proteins in the cytosol, affecting protein 
activity, or enter the nuclear to phosphorylate one or more components of a 
gene regulatory process, altering gene expression (Robinson and Cobb, 
1997).  
 
Classes of MAP kinases 
There are more than a dozen MAPK genes in the human genome. The most 
completely characterized are the extracellular signal regulated kinases 
ERK1/2, the c-Jun N-terminal kinases JNK1-3, ERK5, and the p38 kinases. 
The c-Jun N-terminal kinases/stress activated protein kinases (JNK/SAPK) 
are activated in response to stresses, cytokines, and DNA/protein synthesis 
inhibition. The p38 kinases are activated in response to cell stressors and 
osmotic stress. This particular study focuses on the ERK1/2 family of MAP 
kinases. ERK1 and ERK2 are 42 and 41 kDa respectively, share 83% 
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identity, and are ubiquitously expressed throughout eukaryotic cell types. 
ERK1/2 is activated to varying extents by growth factors, serum, cytokines, 
and microtubule depolymerization. In response, these kinases are known to 
phosphorylate the p90 ribosomal S6 kinase, mitogen and stress activated 
kinase (MSK), and MAPK interacting kinase, among many other targets. 
These and many diverse targets have linked ERK1/2 to cell attachment and 
migration, growth and differentiation. Though ERK1/2 generally localize to 
throughout the cell, activation of ERK1/2 results in translocation to the 
nucleus, where they play a role in interactions with nuclear transcription 
factors. MEK1, which harbors a strong NES, binds to both non-
phosphorylated ERK1 and ERK2, highlighting a mechanism for sequestering 
inactive ERK1/2 in the cytosol (Raman et al., 2007).  
 
MAP kinase phosphatases and MAP kinase cascade regulation 
The first MAP kinase phosphatase, MKP1, was originally cloned as an 
immediate early gene product (3CH134) expressed upon stimulation with 
growth factor. It was found to specifically dephosphorylate MAP kinases at the 
phosphothreonine and phosphotyrosine residues. This dephosphorylation 
was shown to inactivate the catalytic activity of MAP kinases and to suppress 
cellular signaling (Sun et al., 1993). After the discovery of MKP1, nine other 
MKPs were identified on the basis of sequence homology, including a highly 
conserved C terminal domain.  Along with MKP1, MKP3 is extensively 
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studied, and shown to bind specifically to Erk2. Other DUSPs, such as JSP-1 
and SKRP1, have been shown to modulate MAPK signaling through 
upstream regulators, indicating that there are significant, multi-faceted 
mechanisms for the control of MAP kinase pathways by phosphatases 
(Schwertassek et al., 2010).  
 
“Dead” phosphatases and their cellular significance 
The pseudophosphatase STYX is the prototypic pseudophosphatase. It is 
structurally related to the dual-specificity phosphatases but lacks the 
nucleophilic cysteine residue (Wishart and Dixon, 1998). There have been 
many other pseudophosphatases identified; this discovery in conjunction with 
the presence of naturally-occurring pseudokinases suggests that catalytically 
impaired proteins may influence phosphorylation and dephosphorylation in 
vivo (Tonks, 2009).  
 
 Aside from the 10 MAP kinase phosphatases with CH2 motifs, a protein 
called MK-STYX also contains the same motifs and is homologous to the 
MKPs. Interestingly, this protein is naturally catalytically inactive due to the 
substitution of serine and phenylalanine in place of the conserved cysteine 
and histidine residues. MK-STYX thus constitutes a naturally occurring “dead” 
phosphatase, or pseudophosphatase. Despite their catalytically inactive 
status, there is growing evidence that pseudophosphatases may perform 
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regulatory functions in vivo. Mutation of the first discovered MKP, MKP1, at 
the active site led to sustained phosphorylation of MAPK (as opposed to the 
normally transient phosphorylation state of this protein) (Sun et al., 1993). 
Thus, it is possible that the mutant protein binds to its phosphorylated 
substrate, thus blocking catalytically active endogenous phosphatases from 
cleaving the phosphate group. Additionally, expression of the catalytically 
inactive MKP1 mutant was sufficient to generate an accumulation of 
phosphorylated MAP kinase (Sun et al., 1993). This potential for mutated, 
catalytically inactive phosphatases to bind tightly to their substrates has been 
exploited in the elucidation of targets for poorly characterized phosphatases. 
However, these experiments also shed light on possible mechanisms of 
action for pseudophosphatases in mammalian cells.   
 
MK-STYX 
MK-STYX [MAPK (mitogen-activated protein kinase) phospho-
serine/threonine/tyrosine-binding protein] is a pseudophosphatase member of 
the dual-specificity phosphatase subfamily of the PTPs (protein tyrosine 
phosphatases) (Figure 4). MK-STYX is catalytically inactive due to the 
absence of two amino acids from the signature motif that are essential for 
phosphatase activity. The conserved nucleophilic cysteine residue and 
adjacent histidine residue are replaced by serine and phenylalanine residues, 
respectively, in MK-STYX. G3BP [Ras-GAP (GTPase-activating protein) SH3 
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(Src homology 3) domain-binding protein-1], a regulator of Ras signaling, has 
been identified as binding partner of native MK-STYX. MK-STYX is 
homologous to the MKPs, which are responsible for regulating diverse cellular 
signaling pathways.  
G3BP 
The isolation of G3BP (Ras-GTPase activating protein SH3 domain binding 
protein) was reported in 1996 (Parker et al., 1996) (Figure 4). Since then, 
G3BP has been implicated in a diverse array of cellular processes. Mammals 
have 3 G3BPs: G3BP 1, 2a, and 2b, which are the products of differential 
splicing of 2 genes. They are ubiquitously expressed. Structurally, the 
proteins contain an RNA Recognition Motif (RRM), an arginine-glycine rich 
box (RGG box), and a Nuclear Transport Factor 2 (NTF-2) - like domain. 
NTF2 has been involved in RanGTP-dependent nuclear import of proteins 
through the nuclear pore complex (Irvine et al., 2004). The distribution of 
G3BP is primarily cytoplasmic, but it can enter the nucleus (Parker et al., 
1996).  Functionally, all G3BPs bind specifically to the SH3 domain of 
RasGAP, perhaps modulating signaling events downstream of Ras. The 
RNase activity of G3BP is positively regulated by phosphorylation at several 
sites. Serine 149 (ser149), in particular, is dependent on RasGAP and   
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A)
 
B) 
 
 
Figure 4: Schematic Representations of MK-STYX and G3BP.  
MK-STYX (A) has dual specificity and rhodanese domains. MK-STYX is 
catalytically inactive due to the absence of two amino acids (shown) within the 
active site that are essential for phosphatases activity. G3BP (B) has an 
NTF2-like domain as well as an RNA recognition motif. Formation of stress 
granules is regulated by phosphorylation at site 149.  
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negatively regulated by Ras signaling (Parker et al., 1996; Tourriere et al., 
2001).  
 
Stress granule formation 
Cells have evolved protective responses to stresses such as elevated 
temperature, oxidative conditions, or exposure to UV light. One response 
involves the induction of the heat-shock proteins, stress-induced transcription 
factors, and the formation of stress granules (Kedersha et al., 2000; Kedersha 
et al., 1999). Stress granules are large, cytoplasmic structures where 
untranslated mRNAs accumulate (Anderson and Kedersha, 2002; Kedersha 
and Anderson, 2002). Assembly of stress granules can be triggered by the 
phosphorylation of the translation initiation factor eIF2α, which prevents 
formation of the eIF2-GTP-Met-tRNA complex (Kedersha et al., 1999). This 
inhibits protein synthesis and leads to accumulation of the 48S preinitiation 
complex (Kedersha and Anderson, 2002; Kedersha et al., 1999). Stress 
granules contain many components of this complex as a result. Multiple RNA-
binding proteins are associated with the stress granule complex, including 
TIA-1 and TIAR, poly(A)+ binding protein I (PABP-I), and the mRNA 
stabilizing protein HuR (Kedersha and Anderson, 2002; Kedersha et al., 
1999). 
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G3BP and stress granule assembly 
G3BP is diffusely distributed throughout the cytoplasm of untreated cells, but 
when exposed to environmental stresses, such as heat shock, UV irradiation, 
hypoxia, arsenite or high temperature, G3BP becomes localized in large 
cytoplasmic structures called stress granules (Tourriere et al., 2003). Stress 
granules are stalled sites of mRNA translation, where mRNA is triaged and 
sent to other sites of storage, initiation of translation, or degradation. The 
overall effect is to promote expression of proteins that allow the cell to adapt 
to the stress (Kedersha et al., 2005). Additionally, it appears G3BP 
recruitment to stress granules is influenced by Ras. Phosphorylation at site 
149 seems to have an effect on stress granule formation as well; a 
phosphomimetic mutant of G3BP (S149E) was unable to form stress granules 
(Tourriere et al., 2003). This data indicates that G3BP-induced formation of 
stress granules is dependent on dephosphorylation of Ser149, particularly  
because phosphorylation at this site prevents oligomerization of G3BP 
(Tourriere et al., 2003). 
 
Using co-immunoprecipitation studies, G3BP was determined to be a binding 
partner for MK-STYX. MK-STYX reduced stress granule formation in cells 
transfected with a GFP-tagged G3BP expression vector (Hinton et al., 2010). 
Additionally, expression of MK-STYX was observed to result in a dramatic 
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decrease in stress granule formation in arsenite treated cells (Hinton et al., 
2010). 
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Specific aims 
This research aims to answer several primary questions, elucidating the 
importance of protein structure, function, and localization in biological 
processes: 
1. Do v-ErbA aggresomes colocalize with proteasomes?  
2. Do v-ErbA aggresomes colocalize with mitochondria?  
3. What is the effect of the retroviral Gag sequence on v-ErbA 
localization?  
4. Is MK-STYX inhibition of stress granule formation affected by G3BP 
phosphorylation state? 
5. Does MK-STYX have an effect on NGF-stimulated differentiation? 
6. What is MK-STYXʼs effect on the activation state of ERK 1/2? 
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Methods 
Plasmids 
The GFP-250 expression vectors were a generous gift from Elizabeth Sztul 
(University of Alabama) (Fu et al., 2005; Garcia-Mata et al., 1999). The 
aggresomal marker GFP-250 is composed of GFP fused at its C-terminus to 
the first 250 amino acids of p115, a protein involved in the transport of cargo 
from the endoplasmic reticulum to the Golgi (Nelson et al., 1998). GFP, GFP-
TRα1, GFP-Δ Gag-v-ErbA, and YFP-Gag (1–70) expression vectors have 
been previously described (Bonamy et al., 2005; DeLong et al., 2004).   
 
pMT2-FLAG-MK-STYX-FLAG and pMT2-FLAG-MK-STYXactive-FLAG were 
generated as described previously. (Hinton et al., 2010). The integrity of all 
constructs derived from PCR was confirmed by DNA sequencing. The G3BP-
GFP, G3BP149A-GFP, and G3BP149E-GFP constructs were kindly provided 
by Jamai Tazi (Institut de Génétique Moléculaire, France). 
 
Cell culture, transfections and treatments 
HeLa cells (human cervix epithelioid carcinoma; ATCC CCL-2) were grown 
and maintained at 37°C and 5% CO2 in Minimum Essential Medium (Gibco), 
supplemented with 10% fetal bovine serum (Invitrogen). PC12 cells (rat 
pheochromocytoma) were grown and maintained at 37°C and 5% CO2 in 
DMEM high glucose Minimum Essential Medium (Gibco), supplemented with 
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10% fetal bovine serum (Invitrogen).  
 
For transient transfection assays, 1–3 × 105 HeLa cells per 
well were added to each well of a 6-well plate with glass coverslips (Fisher) 
and incubated at 37°C for approximately 24 h.  Alternatively, 1-7 × 105 PC12 
cells were grown on 100-mm round dishes and incubated at 37°C for 
approximately 24 h. Various combinations of plasmid expression vectors were 
introduced using either Lipofectamine or Lipofectamine 2000 (Invitrogen) 
according to the manufacturerʼs recommendations. Cells were fixed 24–48 h 
post- transfection and analyzed by fluorescence microscopy.  
 
For live cell imaging, PC12 cells were plated onto 100 mm plates  (Fisher) 
and incubated at 37°C for approximately 24 hours. Various combinations of 
plasmid expression vectors were introduced using either Lipofectamine or 
Lipofectamine 2000 (Invitrogen) according to the manufacturerʼs 
recommendations. In some experiments, cells were treated with nerve growth 
factor. Cells were imaged 24-48 hours post transfection.  
     
Fixation, immunofluorescence, and organelle staining 
Approximately 24–48 h after transfection, cells were fixed in 3.7% 
formaldehyde and, in some experiments, permeabilized with 0.2% Triton-X-
100 for antibody staining. Antibodies used were as follows: anti-20S 
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proteasome ʻcoreʼ subunits, 1:500 (BioMol); Cy3-goat anti- mouse or Cy3-
goat anti-rabbit, 1:500 (Zymed Laboratories). To visualize mitochondria, cells 
were treated with 10 nM MitoTracker Red (Molecular Probes) approximately 
48 h post-transfection. Upon addition of MitoTracker Red, cells were 
incubated at 37°C for 30 min. After processing, coverslips were mounted onto 
microscope slides in Fluoro-Gel II (Electron Microscopy Sciences) containing 
the DNA counter stain DAPI (4, 6-diamino-2- phenylindole dihydrochloride) 
(Sigma).  
 
Cell scoring and statistical analysis 
For some experiments, prepared slides were analyzed with an Olympus 
fluorescence microscope. Cells were photographed with a Cooke 
SensiCamQE digital camera. IP Lab software and Adobe Photoshop CS were 
used to pseudocolor, and layer the captured images. At least 2–3 replicate 
transfections were performed, with a minimum of 100 cells scored per 
replicate. For PC12 experiments, live cells were analyzed with a Nikon 
Eclipse Ti microscope. NIS Elements software was used to analyze outgrowth 
length. 
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Results 
Part 1: The Targeting of v-ErbA to Aggresomes 
v-ErbA aggresomes recruit proteasomes 
Strong evidence suggests that v-ErbA foci are aggresomal in nature. First, v-
ErbA aggresomes have been shown to associate with aggresome markers 
(Bondzi et al., 2011). Additionally, they have been shown to disrupt the 
vimentin intermediate filaments, depend on the microtubules and the dynein 
motor for formation, and recruit cellular components like HDAC6 (Bondzi et 
al., 2011). 
 
 Aggresomes have been reported to recruit chaperones, ubiquitination 
enzymes, and proteasomes (Garcia-Mata et al., 2002). In order to investigate 
the potential colocalization of GFP-v-ErbA inclusions with proteasomes, HeLa 
cells were transfected with expression vectors for either GFP-250 or GFP-v-
ErbA. Subsequently, we immunostained with anti-20S proteasome subunit 
antibodies (the catalytic core of the 26S proteasome) and observed by 
fluorescence microscopy. In order to increase the amount of mature 
aggresome formation, some cells were treated with MG132. First, we 
investigated the colocalization of the aggresome marker GFP-250 with 20S 
proteasomes. The 20S proteasome subunits showed a diffuse distribution 
throughout the cytoplasm with 59% of cells displaying distinct colocalization of 
a subpopulation of the proteasomes with these aggregates. Of cells that 
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formed cytoplasmic inclusions of GFP-v-ErbA, 68% of cells showed 
colocalization with a subpopulation of 20S proteasome subunits.  
 
v-ErbA aggresomes recruit mitochondria 
The accumulation of proteins at the aggresome causes disorganization of the 
microtubule network. Because microtubules regulate the distribution of cellular 
organelles, this disruption leads to retraction of the mitochondria from the 
periphery to the cell and towards the area of the aggresome and of the viral 
replication factories (Bauer and Richter-Landsberg, 2006; Heath et al., 2001; 
Mittal et al., 2007; Nozawa et al., 2004; Wileman, 2007). It is hypothesized 
that this recruitment takes place to provide energy for the processes of protein 
folding and/or degradation (Waelter et al., 2001). Given that both the 20S 
proteasome subunits and chaperones have been shown to colocalize to the 
aggresome, and both structures require ATP to function, this is plausible 
(Bondzi et al., 2011; Garcia-Mata et al., 1999).  
 
In order to investigate possible association between GFP-250 and GFP-v-
ErbA aggresomes and mitochondria, HeLa cells were stained with 
MitoTracker Red, a mitochondrion-selective dye. In untransfected cells, 
mitochondria were distributed throughout the cytosol. This was true of cells 
transfected with expression vectors for pEGFP and GFP-TRα1. In contrast, in  
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Figure 5: The recruitment of proteasomes to the site of the aggresome. 
Colocalization of 20S proteasome subunits with GFP-250 and v-ErbA 
aggresomes. HeLa cells overexpressing GFP-250 or GFP-v-ErbA) were fixed 
48 h post-transfection and immunostained with anti-20S proteasome 
antibodies (red). In the merged images, yellow indicates colocalization and 
blue indicates nuclei stained with DAPI. 
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61% of cells that formed GFP-250 aggresomes, the foci colocalized with 
mitochondria retracted from the cell periphery.  
 
Prior work indicated that when v-ErbA was present in punctate foci throughout 
the cytoplasm, these pre-aggresomal inclusions did not colocalize with 
mitochondria (Bonamy et al., 2005). In this investigation, v-ErbA foci were 
allowed to mature into full aggresomes. Consequently, colocalization of v-
ErbA with mitochondria was observed in 83% of cells that formed mature 
aggresomes.  
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Figure 6: Mitochondria are recruited to v-ErbA aggresomes. 
In untransfected cells (A), and in cells transfected with pEGFP (B) and GFP- 
TRα1 (C), mitochondria are distributed throughout the cytoplasm. In cells 
transfected with expression vectors for GFP-250 (D) or GFP (E), mitochondria 
colocalized to aggresomes.  
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The AEV Gag sequence is essential for v-ErbA recruitment to 
aggresomes 
 
Viral factors, sites of viral assembly, are utilized by many viruses to increase 
the efficiency of replication by isolating viral components. Similarly to 
aggresomes, viral factories rearrange vimentin, utilize the microtubule tracks, 
converge at the MTOC, and recruit chaperones, ubiquitin, and mitochondria. 
Because v-ErbA is a retroviral oncoprotein, studying its inclusions offers 
insight in the study of both aggresomes and viral factories. v-ErbA is 
expressed by AEV as a Gag-v-ErbA fusion protein. The Gag sequence 
appears to be essential for biological activity of v-ErbA and contains a strong 
nuclear export sequence (DeLong et al., 2004). The viral Gag sequence is 
involved in formation of the viral capsid; it is possible that it is recognized by 
the dynein motors, like other viral components, and it is carried along the 
microtubule tracks towards the nucleus.  
 
In order to investigate the role of the Gag sequence in the formation of v-ErbA 
foci, HeLa cells were transfected with a GFP-ΔGag-v-ErbA (Gag sequence 
deleted) expression vector and viewed by fluorescence microscopy. 
Generally, over 50% of cells expressing GFP-v-ErbA contain large 
cytoplasmic inclusions.   In this experiment, ΔGag-v-ErbA showed a 
significant nuclear population, more diffuse cytoplasmic distribution, and a 
drastic reduction in cytoplasmic foci (~ 1% of cells) (see Figure 7).  Further 
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investigation into the role of the Gag sequence involved the overexpression of 
YFP-tagged Gag (1-70), which has been shown to localize entirely to the 
cytoplasm (DeLong et al., 2004). This protein formed multiple foci in the 
cytoplasm of a subset of the cells.  It is possible that the 70 amino acids at the 
N-terminus play a role in promoting the formation of cytoplasmic inclusions of 
v-ErbA.  
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Figure 7: The AEV Gag sequence plays a role in targeting of v-ErbA to 
aggresomes.  
HeLa cells were transfected with plasmids for GFP-ΔGag-v-ErbA (v-ErbA with 
deletion of Gag sequence). 24 h post-transfection, cells were fixed and 
analyzed by fluorescence microscopy. GFP-ΔGag-v-ErbA was more nuclear 
than GFP-v-ErbA and had few cytoplasmic aggregates compared with GFP-v-
erbA.  
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Part 2: The involvement of MK-STYX in the stress response and 
neuronal differentiation 
 
Inhibition of stress granule assembly by MK-STYX is not wholly G3BP 
phosphorylation dependent 
 
Stress granule assembly is induced by a variety of environmental stressors, 
including heat shock and UV radiation, as well as overexpression of G3BP 
(Tourriere et al., 2003). It has also been shown that MK-STYX binds G3BP 
and decreases stress granule assembly (Hinton et al., 2010). 
Dephosphorylation of G3BP at serine 149 has been shown to induce stress 
granule assembly (Tourriere et al., 2003). To determine whether inhibition of 
stress granule assembly by MK-STYX is phosphorylation-dependent, we 
coexpressed MK-STYX with GFP-tagged G3BP-S149A or G3BP-S149E 
mutants in HeLa cells. This mutant cannot be phosphorylated, nor does it 
possess the charge that might mimic phosphorylation. Consistent with 
previous studies (Tourriere et al., 2003), our study found that G3BP-S149A 
induced stress granule assembly in ~60% of cells expressing the mutant. In 
our research, MK-STYX prevented stress granule assembly; only 35% of cells 
expressing MK-STYX and G3BP-S149A formed stress granules.  
 
The non-phosphorylatable G3BP-S149A mutant mimics dephosphorylated 
G3BP, which is required for stress granule assembly (Tourriere et al., 2003). 
MK-STYX is able to regulate stress granule assembly in cells expressing 
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G3BP-S149E, suggesting that its mode of action is not wholly dependent on 
G3BP phosphorylation state. Additionally, the expression of MK-STYX had no 
effect on stress granule formation in cells expressing the phosphomimetic 
mutant G3BP-S149E.  
 
Intriguingly, the presence of MK-STYX(active mutant) had a significant effect on 
cells expressing the non-phosphorylatable and phosphomimetic 149 mutants. 
Cells expressing G3BP-S149A in the presence of MK-STYX(active mutant) formed 
larger granules, with 55% forming aggregates. Additionally, cells expressing 
the active mutant and G3BP-S149E formed intermediate-sized granules that 
resemble prior studies with MK-STYX and wild type G3BP (Hinton et al., 
2010).  Approximately 53% of cells expressing the phosphomimetic G3BP-
S149E and the active mutant were able to induce stress granule formation, an 
unexpected finding given the necessity of dephosphorylation at site 149 for 
stress granule assembly (Tourriere et al., 2003). 
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Figure 8: Phosphorylation independent inhibition of stress granule 
assembly by MK-STYX.  
 
Representative examples of subcellular distribution of G3BP-S149A-GFP. 
HeLa cells cotransfected with expression constructs for G3BP-S149A-GFP 
and wild-type MK-STYX showed fewer cells with stress granules. The 
overexpression of G3BP-S149A alone resulted in stress granule assembly. 
Cells cotransfected with G3BP-S149A and the active MK-STYX mutant 
accumulated larger perinuclear granules. Green = G3BP-S149A. Blue = DAPI. 
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Figure 9: Phosphorylation independent inhibition of stress granule 
assembly by MK-STYX. 
  
Cells were scored for the presence or absence of stress granules. Three 
replicate experiments were performed (n=100); the error bars indicate +/- 
SEM. 
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Figure 10: Induction of G3BP149E stress granule assembly by the active 
mutant 
 
Representative examples of subcellular distribution of G3BP-S149E-GFP. 
Cells expressing G3BP-S149E mutant alone or in the presence of MK-STYX 
did not accumulate stress granules. However, cells expressing G3BP-S149E 
accumulated small granules throughout the cytoplasm. Green = G3BP-
S149E. Blue = DAPI.
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Figure 11: Induction of G3BP-S149E stress granule assembly by the 
active mutant 
 
Cells were scored for the presence or absence of stress granules. Three 
replicate experiments were performed (n=100); the error bars indicate +/- 
SEM. 
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MK-STYX increases outgrowth formation in PC12 cells 
It has been shown that the DUSP PTEN attenuates G3BP in neuronal cell 
lines (Huang et al., 2005). Thus, we sought to determine whether MK-STYX 
would have similar effects on signaling in neuronal cell lines. In order to do 
this, we selected the PC12 cell as a model. The PC12 cell line is derived from 
a pheochromocytoma of the rat adrenal medulla. After stimulation with nerve 
growth factor, the cell stops growing, forms processes, and becomes 
electrically excitable. After exposure for weeks, the cells can form processes 
up to 500-1000 μm (Greene & Tischler, 1976).  In PC12 cells, binding of NGF 
and EGF to their respective cell surface receptor tyrosine kinases activates 
Ras-MAPK, phosphatidylinositol (PI) 3-kinase, and phospholipase C 
cascades (source). EGF transiently activates ERK1/2 and stimulates cell 
proliferation. NGF stimulation leads to sustained MAPK activity and nuclear 
accumulation of ERK, leading to cell cycle arrest, neurite outgrowth, and 
expression of neural markers (Qiu et al., 2004). 
 
In addition to MAP kinases, PC12 cells also express phosphatases. For 
example, MKP3 mRNA is highly induced after treatment with NGF in PC12 
(Camps et al., 1998). Dual specificity phosphatases may also play a 
regulatory role of the MAPK cascade in this cell line. Overexpression of PTEN 
caused resistance to NGF in PC12 cells, while PTEN knockdown caused 
elevated MAPK signaling (Jia et al., 2010). Even more intriguingly, a rat 
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homologue of G3BP, the only known binding partner of MK-STYX, is 
expressed endogenously in PC12 cells (Parker et al., 1996). Additionally, 
G3BP1 mRNA is induced downstream of human epidermal growth factor 
receptors(Irvine et al., 2004). Given this information, we hope to investigate 
the possibility that MK-STYX is affecting this process through either regulation 
of the MAPK or the principal MKPs (see Figure 3).  
 
In order to test what effects MK-STYX might have on neuronal cells, we used 
PC12 cells as a model. We performed transient cotransfections using the 
expression vectors for pEGFP and pMT2-FLAG or pMT2-FLAG-MK-STYX-
FLAG. In cells that expressed these constructs, 33% of cells expressing MK-
STYX formed outgrowths, as compared to 2% of untransfected cells (Figure 
12). Cells expressing MK-STYX exhibited multiple small outgrowths (Figure 
15).  
 
MK-STYX increases outgrowth length in cells treated with NGF 
To determine MK-STYX effects on the normal cellular signaling in response to 
growth factors such as NGF, we performed transient cotransfections in PC12 
using expression vectors for pEGFP and pMT2-FLAG or pMT2-FLAG-MK-
STYX-FLAG. In cells that expressed these constructs, we observed a 
dramatic shift in the distribution of outgrowth length (Figure 13). The largest 
shift was in the categories of 20-40 μm and 40-60 μm (the diameter of a 
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PC12 cell ranges from 6-14 μm). This data would suggest that MK-STYX is 
enhancing MAPK signaling in the PC12 cell. Interestingly, however, our 
preliminary Western blotting data suggests that ERK 1/2 phosphorylation, and 
thus activation, is actually lower in cells expressing MK-STYX. Thus, further 
explanation is needed to determine which MAPK MK-STYX is affecting to 
achieve this response.  
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Figure 12: MK-STYX promotes outgrowth formation in PC12 cells. 
In order to perform a preliminary investigation of MK-STYXʼs effects on 
outgrowth formation, PC12 cells were transfected with either pEGFP & pMT2 
or EGFP & MK-STYX. Co-expression of pEGFP allowed visualization of 
successful transfection and cell morphology. Cells were fixed and analyzed 
24 h post-transfection for neurite outgrowth. Cells were scored (n=100) for the 
presence or absence of outgrowths.  
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Figure 13: MK-STYX causes a shift in the distribution of outgrowth 
lengths.  
 
PC12 cells were transfected with either pEGFP & pMT2 or pEGFP & MK-
STYX. Co-expression of pEGFP allowed visualization of successful 
transfection. Cells were treated with 100 ng NGF 24 h post-transfection. 48 h 
post-transfection, cells were visualized using a combination of phase contrast 
and fluorescence microscopy. Cells were scored (n=200) for outgrowth length 
using NIS Elements software.  
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Figure 14: MK-STYX causes the most significant shifts between 20 and 
60 μm.  
 
PC12 cells were transfected with either EGFP & pMT2 or EGFP & MK-STYX. 
Co-expression of EGFP allowed visualization of successful transfection. Cells 
were treated with NGF 24 h post-transfection. 48 h post-transfection, cells 
were visualized using a combination of phase contrast and fluorescence 
microscopy. Cells were scored (n=200) for outgrowth length using NIS 
Elements software. Error bars indicate +/- SEM.  
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A) pEGFP + pMT2 
 
 
B) pEGFP + MK-STYX 
 
 
 
Figure 15: MK-STYX affects the morphology of untreated cells.  
 
PC12 cells were transfected with either p EGFP & pMT2 or pEGFP & MK-
STYX. 48 h post-transfection, cells were visualized using a combination of 
phase contrast and fluorescence microscopy. Cells expressing MK-STYX (B) 
display small outgrowths surrounding the cell in 33% of cases, unlike those 
expressing the empty vector (A).  
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A) pEGFP + pMT2 
 
B) pEGFP + MK-STYX 
  
 
Figure 16: MK-STYX elongates outgrowths in cells treated with NGF 
PC12 cells were transfected with either pEGFP & pMT2 or pEGFP & MK-
STYX. Co-expression of EGFP allowed visualization of successful 
transfection. Cells were treated with 100 ng  
NGF 24 h post-transfection. 48 h post-transfection, cells were visualized 
using a combination of phase contrast and fluorescence microscopy. A – 
pEGFP + pMT2, B – pEGFP + MK-STYX.   
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Discussion 
Part 1: The Targeting of v-ErbA to aggresomes 
Prior research in the Allison lab indicated that the v-ErbA oncoprotein forms 
cytoplasmic foci and that a significant portion of cellular TRα in these foci; this 
likely contributes to the proteinʼs oncogenic properties (Bonamy and Allison, 
2006; Bonamy et al., 2005).  Additionally, research in the Allison lab indicates 
that a subpopulation of v-ErbA aggregates colocalize with aggresomal 
markers (such as GFP-250), recruit HDAC6 and chaperones, disrupt vimentin 
intermediate filaments, and are enhanced in size upon treatment with 
proteasome inhibitors (Bondzi et al., 2011).  Formation of v-ErbA foci is also 
microtubule- and dynein-dependent (Bondzi et al., 2011).  This thesis 
research provides further support for the targeting of v-ErbA to aggresomes; 
both mitochondria and proteasomes are recruited to the site of v-ErbA foci. 
Additionally, aggresome formation appears to be dependent on the viral Gag 
sequence.  
 
Significance of recruitment of mitochondria and proteasomes  
v-ErbA is an oncoprotein carried by the avian erythroblastosis virus (AEV) 
that mislocalizes to cytoplasmic foci, sequestering the thyroid hormone in 
heterodimers within these foci; this property contributes to its oncogenic 
properties (Bonamy et al., 2005). This thesis research provides evidence that 
these cytoplasmic foci that are aggresomal in nature, recruit proteasomes and 
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mitochondria, and are reliant upon the Gag sequence for formation. These 
results indicate that v-ErbA foci are aggresomes, but also that they may 
represent a holdover from viral replication.  
 
It is possible that the targeting of v-ErbA to aggresomes is a cellular response 
to the accumulation of the mutant protein in the cytoplasm. If so, the 
aggresome serves as a mechanism of sequestering the protein for disposal 
by the proteasome machinery. Our data indicates that proteasomes are 
recruited to the site of the aggresome, presumably to aid in the degradation 
process. The 20S proteasome subunit has been shown to localize to the 
aggresome (Garcia-Mata et al., 1999), despite evidence that proteasome-
mediated degradation is not particularly efficient at the aggresome (Garcia-
Mata et al., 2002).   
 
Additionally, we found that mitochondria were recruited to the site of the v-
ErbA aggresomes. It has been postulated that mitochondria are recruited to 
aggresomes to provide energy for protein folding and/or degradation (Waelter 
et al., 2001). It is also possible that because v-ErbA causes the disruption of 
the vimentin intermediate filaments (Bondzi et al., 2011), the reorganization of 
the mitochondria could be a side effect of the disturbance of the cytoskeleton.  
Mitochondria have also been shown to be involved in apoptotic pathways, so 
it is possible that mitochondria, once recruited to the aggresome, engage in 
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signaling pathways that promote apoptosis (Cereghetti and Scorrano, 2006; 
Debure et al., 2003; Soo et al., 2009).  
 
Significance of the viral Gag sequence in v-ErbA localization 
It is also plausible that targeting of v-ErbA to aggresomes is a remnant viral 
behavior for assembly at a viral factory. While the aggresomal response is 
likely adapted to reduce the toxicity of misfolded proteins, viruses may exploit 
it as a way to gather structural components necessary for viral assembly in a 
central location (Wileman, 2006). Viral factories have been shown to 
colocalize with the aggresome marker GFP-250, and like aggresomes they 
are dependent upon the microtubules for assembly and disrupt vimentin 
intermediate filaments (Arnaud et al., 2007; Heath et al., 2001; Liu et al., 
2005). v-ErbA is a fusion protein containing a portion of the AEV Gag 
sequence, which encodes structural proteins that form the viral capsid. Prior 
studies indicate that the Gag portion of v-ErbA mediates CRM1-dependent 
nuclear export (DeLong et al., 2004). v-ErbA has also been shown to have a 
more nuclear localization when the Gag sequence is deleted (DeLong et al., 
2004). This thesis research indicates that deletion of the Gag sequence 
results in aggresome formation in less than 1% of cells, partially because of 
the predominantly nuclear localization. This data supports the hypothesis that 
the formation of v-ErbA foci is mediated by the Gag sequence, and that this 
represents a remnant of viral assembly at viral factories.  
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Aggresomes: cytoprotective or pathogenic? 
v-ErbA can bind to TRα and sequester the receptor in cytoplasmic foci, 
preventing the regulation of target genes in response to the thyroid hormone 
(Bonamy and Allison, 2006; Bonamy et al., 2005; Bondzi et al., 2011). Other 
dominant negative variants of TRα form cytoplasmic foci (Bunn et al., 2001; 
Lee and Mahdavi, 1993). It is thus possible that this mislocalization plays a 
role in their repressive action as well. Mutations in TR genes are associated 
with endocrine disorders and human cancers (Chan and Privalsky, 2009; 
Chan and Privalsky, 2010), and have been associated with a mouse model of 
thyroid cancer (Zhu et al., 2010). There is significant potential that 
mislocalization of thyroid hormone receptor variants is key in their 
pathogenesis. 
 
Characterizing v-ErbA aggresomes helps in answering a key question in 
studies of protein aggregation: are these mechanisms cytoprotective or 
pathogenic? Given the association between protein aggregation and such 
disorders as cystic fibrosis, Alzheimerʼs, and Parkinsonʼs (Johnston et al., 
1998), it is tempting to hypothesize that aggresomes are detrimental to the 
cell. Alternatively, the recruitment of chaperones, proteasomes, mitochondria, 
and other cellular components suggests that this is a mechanism utilized by 
the cell in order to sequester the protein in order to degrade it.  
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Future directions 
To further investigate the cytoprotective or pathogenic nature of v-ErbA 
aggresomes, it would be helpful to continue to investigate the role of the 
mitochondria at the site of the aggresome. One potential is to test for 
apoptotic markers at the site of the aggresome.  
 
Given the association between thyroid hormone receptor mutations and 
disease, further characterization of the effects of other thyroid hormone 
receptor mutations on cellular localization could clarify the role of 
mislocalization in dominant negative activity.  
 
Part 2: The involvement of MK-STYX in the stress response and 
neuronal differentiation 
 
A role for pseudophosphatases in cell signaling 
Several pseudophosphatases have been identified with a diverse range of 
functions (Azzedine et al., 2003; Conner et al., 2006; Tonks, 2009; Wishart 
and Dixon, 1998). While these proteins adopt a similar structure, they lack key 
residues that are essential for catalytic activity and thus will not be able to 
cleave phosphate groups from their target substrates. Despite their lack of 
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catalytic activity, however, these proteins have meaningful effects on 
signaling pathways. This highlights the importance of protein-protein 
interactions.  
 
MK-STYX is a pseudophosphatase member of the MAP kinase phosphatase 
class of dual specificity phosphatases (Hinton et al., 2010). MK-STYX is 
catalytically inactive due to the absence of two key residues in the active site 
that are essential for phosphatase activity (Andersen et al., 2004; Hinton et 
al., 2010). Mutations made in these key residues restored catalytic activity 
(Hinton et al., 2010).  It consists of a PTP domain, as well as a rhodanese 
domain homologous to the cdc25 (cell dependent cyclin phosphatase 25kDa) 
(Keyse and Ginsburg, 1993; Wishart and Dixon, 1998). The PTP domain 
carries out the catalytic activity, while the rhodanese domain is thought to act 
as a docking domain for MAPKs (Hofmann et al., 1998). MKPs are known to 
bind to MAPKs to dephosphorylate and deactivate them (Camps et al., 1998; 
Sun et al., 1993; Sun et al., 1994). Given MK-STYXʼs homology to MKPs, the 
most likely target for MK-STYX would be MAPKs, particularly ERK1/2.  
However, MK-STYX has diverse binding capabilities and functions, including 
acting as a regulator of G3BP in response to stress and as an effector in the 
apoptotic pathway (Hinton et al., 2010; Niemi et al., 2011). This thesis 
research has provided further evidence that MK-STYX is a dynamic regulator 
of cell signaling pathways.  
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Significance of MK-STYXʼs effects on stress granule assembly  
MK-STYX has been shown to bind G3BP (Hinton et al., 2010), an RNA-
binding protein that is a regulator of Ras function and stress granule assembly 
(Tourriere et al., 2003; Tourriere et al., 2001). It has been shown that MK-
STYX inhibits stress granule formation induced by G3BP, while the active 
mutant does not have this effect (Hinton et al., 2010). Dephosphorylation at 
Ser149 of G3BP is necessary for the formation of stress granules (Tourriere 
et al., 2003). The G3BP-S139A mutant is designed to mimic 
dephosphorylation at site 149. Interestingly, our results show that MK-STYX 
inhibits stress granule assembly induced by the non-phosphorylatable mutant 
G3BP-S149A. These results indicate that MK-STYX is capable of inhibiting 
stress granule assembly independent of G3BPphosphorylation state. 
Additionally, while MK-STYX does not have an effect on cells expressing the 
phosphomimetic mutant G3BP-S149E, the active mutant induces stress 
granule assembly in these cells. These results highlight MK-STYX as a 
potential regulator of G3BP and stress granule formation. Potentially, MK-
STYX may regulate the disassembly of stress granules. Additionally, this 
study provides further evidence that pseudophosphatases such as MK-STYX 
are more than dominant negative proteins that block phosphatase function, 
but rather powerful signaling regulators.  
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Significance of MK-STYX effects on MAPK signaling in neurons 
MAPK cascades regulate diverse cellular responses including growth, 
differentiation, apoptosis, and proliferation (Schaeffer and Weber, 1999). 
MAPKs are abundantly expressed throughout the nervous system, so it is no 
surprise that their misregulation should be particularly interesting with respect 
to neurological disorders. Both decreased and increased levels of MAPK 
activation have been linked to mental retardation, impaired learning, and 
memory loss (English and Sweatt, 1996; English and Sweatt, 1997; Peng et 
al., 2010; Sweatt, 2001). Neurological disorders have been linked to both 
hyperphosphorylation and the inhibition of MAPK phosphorylation.  
 
The significance of MAPK signaling cascades in proper neurological function 
is becoming increasingly clear.  However, not much is known about the 
regulation of the MAPK signaling pathways. There are several phosphatases 
that serve as regulators of MAPK signaling; a good example is the PTP SHP-
2 (Easton et al., 2006; Shi et al., 1998; Wright et al., 1997). It would appear 
that MK-STYX may play a role in modulating response to cellular signaling 
molecules. Additionally, G3BP, a known binding partner of MK-STYX, has 
been implicated in neuronal outgrowth formation and interacts with axonal tau 
mRNA (Atlas et al., 2004).  
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Future Directions 
The evidence we have gathered suggests that MK-STYX may be interacting 
with another MAPK or signaling protein in order to stimulate neuronal 
differentiation. Other MAPKs have been implicated in PC12 differentiation, 
including p38 (Iwasaki et al., 1999; Morooka and Nishida, 1998); it has even 
been suggested that activation of the p38 MAPK alone can induce neuronal 
differentiation of PC12 cells (Iwasaki et al., 1999). Further investigation of this 
connection would involve the use of PD98059, a small molecule that 
selectively blocks the activity of MEK, inhibiting phosphorylation and 
activation of ERK1/2 in vivo (Alessi et al., 1995; Pang et al., 1995). If MK-
STYX stimulates outgrowth formation in the presence of this inhibitor, it would 
suggest involvement of other pathways, particularly p38. Particularly, though, 
this research indicates a dynamic role for MK-STYX and other 
pseudophosphatases in regulation of cellular signaling mechanisms. Far from 
being simple antagonists of their active homologues, pseudophosphatases 
are emerging as key players in a variety of physiological mechanisms.  
 
Summary 
The preceding thesis research has provided evidence for the importance of 
cellular signaling to normal cellular functions. v-ErbA, a mutated variant of the 
thyroid hormone receptor, interferes with the normal processes of the cell. 
This protein forms large, cytoplasmic foci that may act as a cellular 
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mechanism to deal with this misregulation of cellular response to the thyroid 
hormone receptor. MK-STYX, a pseudophosphatase, is also involved in the 
response to environmental cues.  The first, stress granule formation, is a 
cellular response to high stress conditions. The second is the normal 
physiological process of differentiation in PC12 cells.  
 
This work highlights aggregation as a cellular mechanism to deal with stress, 
whether it is viral infection or an overload of misfolded proteins (aggresomes), 
or stressors such as UV irradiation or heat shock (stress granules). Key in the 
formation of these aggregates are complex cell signaling mechanisms, the 
misregulation of which can be detrimental to the cell.  
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